Open house drug rebate agreements Eltrombopag, excluding indication severe aplastic anaemia in the product information, unless the manufacturer enjoys patent protection for this, ATC B02BX05
Open house Arzneimittelrabattverträge Eltrombopag, ausgeschl. Anwendungsgebiet schwere aplastische Anämie in der Fachinformation, es sei denn, der Hersteller genießt hierfür Patenschutz, ATC B02BX05
Germany
Contract
BuyerAOK Bayern - Die Gesundheitskasse
TypeSupplies
Estimated valuevalue not published
Published14 August 2025
CategoryMedical equipment & pharma · CPV 33000000
Who has won here before
| Company | Awards | Period |
|---|---|---|
| ratiopharm GmbH | 56 | 2014–2023 |
| Hexal AG · Holzkirchen | 46 | 2011–2022 |
| Aliud Pharma GmbH · Laichingen | 45 | 2011–2023 |
| Haemato Pharm GmbH · Schönefeld | 43 | 2014–2022 |
| Orifarm GmbH · Leverkusen | 39 | 2018–2023 |
From 13.7M documented awards · regular winners know this buyer's requirements — that is your competition.
How often this buyer tenders this
2019269
2020363
2021221
2022268
2023319
2024467
20254
2025704
2026392
Who knows the rhythm prepares instead of reacting.
348
days until the deadline — Tuesday 3 August at 10:00
How to bid
Read the full notice — Original + documents
Goes directly to this tender on Vergabemarktplatz (cosinex). The full specification and all annexes are there.
Tenders like this, every morning at 7:30 in your inbox.
Start free →